BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10851967)

  • 1. Room for improvement in stroke treatment.
    Health News; 2000 May; 6(5):5. PubMed ID: 10851967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Waran following thrombolysis with Actilyse].
    Ohlsson S; Böttiger Y
    Lakartidningen; 2006 Mar 15-21; 103(11):853. PubMed ID: 16613115
    [No Abstract]   [Full Text] [Related]  

  • 3. A response to "Dental implications of acute stroke therapy and anticoagulation for stroke prevention".
    Stoopler ET
    Compend Contin Educ Dent; 2010 Jun; 31(5):322. PubMed ID: 20583500
    [No Abstract]   [Full Text] [Related]  

  • 4. When time matters most. Group working on new stroke readiness program.
    Lovern E
    Mod Healthc; 2001 Jun; 31(25):88. PubMed ID: 11436396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quicker thrombolytic treatment in stroke?].
    Johnsen SH
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2213. PubMed ID: 19898566
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Morris DC
    N Engl J Med; 2008 Dec; 359(26):2841; author reply 2841. PubMed ID: 19115492
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Schwamm LH; Fonarow GC
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Fitzpatrick AE; Noone I; O'Shea DD
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
    [No Abstract]   [Full Text] [Related]  

  • 9. The timing of thrombolysis for strokes complicating cardiac catheterization.
    De Marco F; Routledge H; Lefèvre T
    J Am Coll Cardiol; 2008 Jul; 52(4):317; author reply 317-8. PubMed ID: 18634993
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolytic therapy for acute stroke--not a moment to lose.
    Lyden P
    N Engl J Med; 2008 Sep; 359(13):1393-5. PubMed ID: 18815401
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in stroke management: update 1998.
    Hacke W
    Neurology; 1999; 53(7 Suppl 4):S1-2. PubMed ID: 10532642
    [No Abstract]   [Full Text] [Related]  

  • 13. The ECASS III results and the tPA paradox.
    Davis S; Donnan G
    Int J Stroke; 2009 Feb; 4(1):17-8. PubMed ID: 19236491
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
    Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
    Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke-MRI: extending the time-window: recent trials and clinical practice.
    Köhrmann M; Schellinger PD
    Int J Stroke; 2007 Feb; 2(1):53-4. PubMed ID: 18705990
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteplase beyond three hours in ischemic stroke: do we know enough?
    Jawaid A; Fitch O; Qureshi S; Wilson AM; Schulz PE
    Int J Stroke; 2009 Apr; 4(2):70. PubMed ID: 19383044
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the use of intravenous recombinant tissue plasminogen activator from northwest India.
    Pandian JD; Bhullar RS; Kaur P; Dhillon S; Toor G; Singh Y
    Int J Stroke; 2012 Jun; 7(4):363-4. PubMed ID: 22583526
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous thrombolysis with rt-PA in acute stroke patients aged >or=80 years.
    Toni D; Lorenzano S
    Int J Stroke; 2009 Feb; 4(1):21-2. PubMed ID: 19236493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.